ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Validation of a Proteomic-Based Prognostic Model for Breast Cancer and Immunological Analysis

Yu, Yunlin; Dong, Linhuan; Dong, Changjun; Zhang, Xianlin*china three gorges univ
International Journal of Genomics2023-12-16DOI: 10.1155/2023/1738750
13阅读
引用收藏
分享

摘要

Breast cancer (BC) has emerged as an extremely destructive malignancy, causing significant harm to female patients and society at large. Proteomic research holds great promise for early diagnosis and treatment of diseases, and the integration of proteomics with genomics can offer valuable assistance in the early diagnosis, treatment, and improved prognosis of BC patients. In this study, we downloaded breast cancer protein expression data from The Cancer Genome Atlas (TCGA) and combined proteomics with genomics to construct a proteomic-based prognostic model for BC. This model consists of nine proteins (HEREGULIN, IDO, PEA15, MERIT40_pS29, CIITA, AKT2, CD171 DVL3, and CABL9). The accuracy of the model in predicting the survival prognosis of BC patients was further validated through risk curve analysis, survival curve analysis, and independent prognostic analysis. We further confirmed the impact of differential expression of these nine key proteins on overall survival in BC patients, and the differential expression of the key proteins and their encoding genes was validated using immunohistochemical staining. Enrichment analysis revealed functional associations primarily related to PPAR signaling pathway, steroid hormone metabolism, chemokine signaling pathway, DNA conformation changes, immunoglobulin production, and immunoglobulin complex in the high- and low-risk groups. Immune infiltration analysis revealed differential expression of immune cells between the high- and low-risk groups, providing a theoretical basis for subsequent immunotherapy. The model constructed in this study can predict the survival of BC patients, and the identified key proteins may serve as biomarkers to aid in the early diagnosis of BC. Enrichment analysis and immune infiltration analysis provide a necessary theoretical basis for further exploration of the molecular mechanisms and subsequent immunotherapy.

学科与关键词

关键词
PATHWAYPEA-15CELLSRNA
相关
加载中…
  • Characterization of protein-based risk signature to predict prognosis and evaluate the tumor immune environment in breast cancer
    Qing, Xin; Yuan, Chunlei*; Wang, Ke*Breast Cancer, 2023, 30(3): 424-435.
  • A Novel Framework to Predict Breast Cancer Prognosis Using Immune-Associated LncRNAs
    Huang, Zhijian; Xiao, Chen; Zhang, Fushou; Zhou, Zhifeng; Yu, Liang; Ye, Changsheng*; Huang, Weiwei*; Li, Nani*Frontiers in Genetics, 2021, 11: 634195.被引 8
  • Novel immune-related prognostic model and nomogram for breast cancer based on ssGSEA
    Li, Linrong; Li, Lin; Liu, Mohan; Li, Yan*; Sun, Qiang*Frontiers in Genetics, 2023, 13: 957675.
查看全部 →

发表信息

论文状态
公开发表
期刊
International Journal of Genomics
发表日期
2023-12-16
卷期
第 2023 卷
页码
1738750
DOI
10.1155/2023/1738750
语言
ENGLISH
成果收录
SCIE
资助标注
Health Commission of Hubei Province [WJ2019H559]; Joint Fund Project of the Hubei Provincial Health Commission

作者

  • Y

    Yu, Yunlin (第一作者)

    china three gorges univ

  • D

    Dong, Linhuan

    china three gorges univ

查看全部 4 位作者收起作者
  • D

    Dong, Changjun

    china three gorges univ

  • Z

    Zhang, Xianlin (通讯)

    china three gorges univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417